STOCK TITAN

Novanta Inc Stock Price, News & Analysis

NOVT Nasdaq

Welcome to our dedicated page for Novanta news (Ticker: NOVT), a resource for investors and traders seeking the latest updates and insights on Novanta stock.

Novanta Inc (NOVT) delivers precision photonic components and motion-control systems powering innovations in medical technology and industrial automation. This dedicated news hub provides investors and industry professionals with direct access to official press releases and verified updates about the company's technological advancements.

Discover comprehensive coverage of Novanta's latest developments including product launches for minimally invasive surgery tools, strategic partnerships in robotics, and innovations in laser-based manufacturing systems. Our curated feed ensures you stay informed about earnings announcements, leadership updates, and patent filings that demonstrate NOVT's leadership in mission-critical OEM solutions.

Key updates focus on the company's Medical Solutions segment enhancing surgical workflows and Automation Enabling Technologies driving smart manufacturing. Track progress in RFID-based hospital systems and high-precision components for additive manufacturing – all critical to Novanta's dual-market strategy.

Bookmark this page for streamlined access to NOVT's evolving role in medical device innovation and industrial automation. Check regularly for authoritative updates on photonics advancements and motion-control technologies shaping next-generation healthcare and manufacturing ecosystems.

Rhea-AI Summary

Novanta Inc. (Nasdaq: NOVT) is set to release its third quarter 2021 financial results on November 09, 2021. The company will also host a conference call at 10:00 a.m. ET on the same day to discuss these results. Interested parties can join the call by dialing (888) 346-3959 or through a live webcast on the company’s website. A replay will be available three hours post-call until January 03, 2022.

Novanta provides advanced technology solutions aimed at enhancing the competitive edge of healthcare and industrial OEMs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
-
Rhea-AI Summary

Novanta Inc. (NASDAQ: NOVT) announced that CEO Matthijs Glastra and CFO Robert Buckley will present at Baird's 2021 Global Healthcare Conference on September 15, 2021. This virtual event focuses on the company's role as a technology partner to medical and advanced technology OEMs, showcasing its expertise in photonics, vision, and precision motion. Novanta's solutions provide competitive advantages through tailored components that meet demanding applications. The company emphasizes innovation and customer success as core drivers of its growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
conferences
-
Rhea-AI Summary

Novanta Inc. (NASDAQ: NOVT) has successfully completed the acquisitions of Schneider Electric Motion USA Inc. (SEM) and ATI Industrial Automation Inc. (ATI). These strategic acquisitions are set to enhance Novanta’s capabilities in the precision motion and robotics sectors. The Company has also updated its financial guidance for 2021, expecting GAAP revenue between $685 million and $700 million, with Adjusted EBITDA ranging from $145 million to $148 million, and Adjusted Diluted EPS between $2.40 and $2.50.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
Rhea-AI Summary

Novanta reported strong financial results for Q2 2021, achieving GAAP revenue of $167.5 million, up 15.8% from Q2 2020. Bookings soared 77% year-over-year, highlighting robust customer demand. Operating income rose to $16.0 million, while adjusted diluted EPS increased to $0.62 from $0.48. The company expects continued growth, projecting Q3 revenue between $165 million and $170 million and full-year revenue of $660 million to $670 million. Future growth is anticipated from pending acquisitions of ATI and SEM.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
-
Rhea-AI Summary

Novanta Inc. (NASDAQ: NOVT) has agreed to acquire ATI Industrial Automation for $172 million in cash, with additional contingent payments based on ATI's 2021 performance. ATI specializes in intelligent end-of-arm technology solutions for robotics in industrial and medical applications, expecting over $70 million in revenue for 2021. The acquisition aims to enhance Novanta's position in robotics, particularly in electric vehicles and medical sectors, creating a $250 million Precision Motion Segment. The deal is expected to close in Q3 2021 and to be accretive to Novanta's earnings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.69%
Tags
-
Rhea-AI Summary

Novanta Inc. (Nasdaq: NOVT) will announce its second quarter 2021 results on August 10, 2021, followed by a conference call at 10:00 a.m. ET. Participants can join by dialing (888) 346-3959 or via a live webcast. The audio replay will be available approximately three hours post-call until October 4, 2021. Novanta specializes in providing advanced technology solutions for healthcare and industrial OEMs, focusing on photonics, vision, and precision motion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
Rhea-AI Summary

Novanta Inc. (NASDAQ: NOVT) has announced an agreement to acquire Schneider Electric Motion USA for $115 million in cash, with an expected close in the third quarter of 2021. SEM specializes in motion control components for automation, enhancing Novanta's capabilities in robotics and medical technology. This acquisition aligns with Novanta's strategy to expand its precision motion control portfolio and increase exposure to Life Sciences and Medical markets. The deal is projected to be accretive to Novanta's free cash flow and non-GAAP earnings per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.17%
Tags
-
Rhea-AI Summary

Novanta Inc. (Nasdaq:NOVT), a trusted partner to medical and advanced technology manufacturers, announced that CFO Robert Buckley will present at the 21st Annual CJS Securities New Ideas Summer Conference on July 13, 2021. The conference will be held virtually.

About Novanta: Novanta is a leading global supplier of core technology solutions, specializing in photonics, vision, and precision motion. The company provides engineered components and sub-systems designed for extreme precision and performance, catering to the demands of OEMs in medical and industrial sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
conferences
-
Rhea-AI Summary

Novanta Inc. (Nasdaq: NOVT) announced that CEO Matthijs Glastra and CFO Robert Buckley will present at Baird's 2021 Global Consumer, Technology & Services Conference on June 8, 2021. This virtual event showcases Novanta's role as a key technology partner for medical and advanced technology OEMs, emphasizing its expertise in photonics, vision, and precision motion. The company's innovative professionals are committed to delivering high-performance solutions tailored to customer needs, positioning Novanta as a leader in core technology solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
conferences

FAQ

What is the current stock price of Novanta (NOVT)?

The current stock price of Novanta (NOVT) is $121.9 as of May 22, 2025.

What is the market cap of Novanta (NOVT)?

The market cap of Novanta (NOVT) is approximately 4.7B.
Novanta Inc

Nasdaq:NOVT

NOVT Rankings

NOVT Stock Data

4.73B
35.65M
0.9%
102.99%
4.93%
Scientific & Technical Instruments
Miscellaneous Electrical Machinery, Equipment & Supplies
Link
United States
BEDFORD